NASDAQ | ETF
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market.
Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 8.54% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.64% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 5.56% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 4.97% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.87% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.74% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.41% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 3.21% |
| ARGX | Argen-X | Healthcare | Biotechnology | 2.97% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 2.83% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.66% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.66% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 2.34% |
| EL | EssilorLuxottica S. A. | Healthcare | Medical Instruments & Supplies | 2.27% |
| MCK | McKesson Corporation | Healthcare | Medical Distribution | 2.22% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.16% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 1.97% |
| SAN | Sanofi SA | Healthcare | Drug Manufacturers - General | 1.95% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 1.94% |
| UCB | UCB SA | Healthcare | Biotechnology | 1.93% |